We are live on ! Find out more
MG

Meditor Group Portfolio holdings

AUM $48.1M
1-Year Est. Return 38.67%
This Fund
S&P 500
This Quarter Est. Return
+0.75%
1 Year Est. Return
+38.67%
3 Year Est. Return
+41.15%
5 Year Est. Return
+72.2%
10 Year Est. Return
+1,065.64%
AUM
$148M
AUM Growth
-$2.43M
Cap. Flow
-$3.44M
Cap. Flow %
-2.33%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
EXEL icon
Exelixis
EXEL
+$3.44M

Sector Composition

Rank Sector Weight
1 Healthcare 90.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXEL icon
1
Exelixis
EXEL
$13.9B
$106M 71.63%
6,605,186
-211,114
-3% -$3.44M
ESPR
2
DELISTED
Esperion Therapeutics
ESPR
$27.8M 18.82%
4,468,835
– –
INDA icon
3
iShares MSCI India ETF
INDA
$6.71B
$7.15M 4.83%
171,200
– –
EPI icon
4
WisdomTree India Earnings Fund ETF
EPI
$2.02B
$6.97M 4.71%
213,800
– –

Similar funds

BHCM
Boulder Hill Capital Management New York $47.9M AUM
VMV
Venrock Management VI Palo Alto, California $47.6M AUM 45.26% 1-Year Est. Return
BHH
Baker Hughes Holdings Houston, Texas $47.6M AUM 26.35% 1-Year Est. Return
LAMC
Lubert-Adler Management Company Philadelphia, Pennsylvania $49.3M AUM 17.46% 1-Year Est. Return
MAM
Miria Asset Management St. Julians, Malta $49.9M AUM 21.84% 1-Year Est. Return
BCM
BlueMar Capital Management Miami, Florida $49.9M AUM 28.76% 1-Year Est. Return
LOF
Lightspeed Opportunity Fund Menlo Park, California $50.1M AUM 53.1% 1-Year Est. Return
CLCM
Center Lake Capital Management West Palm Beach, Florida $45.8M AUM 58.23% 1-Year Est. Return

Meditor Group's Q4 2022 Portfolio in Review

As of Q4 2022, Meditor Group held 4 positions worth $148M, down 1.6% from $150M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2022: portfolio turnover was 0%. Meditor Group opened no new positions and made no exits, leaving the 4-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, down from 91% a quarter earlier.

  • Meditor Group's biggest Q4 2022 reduction was Exelixis, cutting an estimated $3.44M.
  • Meditor Group's ten largest holdings make up 100% of its $148M portfolio in Q4 2022.
  • Meditor Group opened 0 new positions and closed 0 in Q4 2022.
  • Meditor Group's portfolio value fell 1.6% quarter-over-quarter to $148M.

Based on Meditor Group's 13F filing for Q4 2022, filed 5 Jan 2023.